// App-Quantinova.ai

595 : Monoclonal and Oligoclonal Bands After Single Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Impact On Overall Survival and Progression-Free Survival

Researchers

Presenter

  • Norman Franke

Principal Investigators

  • Andrew Winter Sr

  • Suzanne Trudel

  • Christine I. Chen

  • Rodger E. Tiedemann

  • Vishal Kukreti

Medical Centers

  • Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • McLaughlin Centre for Molecular Medicine, Princess Margaret Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Monoclonal gammopathy

  • Multiple Myeloma

Biomarkers

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • Thalidomide

  • Bortezomib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved